Mauro Gualano, Director of the board at Q-linea, was recently interviewed at the Swiss Nordic Bio 2025 conference in Zurich. Swiss Nordic Bio is a high-level partnering and investor conference aimed at connecting healthcare innovations, investor and industry. Watch the interview here.